FDA Import Refusal 1FX-2303588-5/10002/2 — Exemed Pharmaceuticals

Exemed Pharmaceuticals — FEI 3005822020

The FDA refused shipment 1FX-2303588-5/10002/2 from Exemed Pharmaceuticals (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.